e-learning
resources
2021
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cardiac biomarkers and long-term outcomes of exacerbations of COPD: a long-term follow-up of two cohorts
Eskandarain Shafuddin, Sarah M. Fairweather, Catherina L. Chang, Christine Tuffery, Robert J. Hancox
Source:
ERJ Open Res, 7 (1) 00531-2020; 10.1183/23120541.00531-2020
Journal Issue:
January
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Eskandarain Shafuddin, Sarah M. Fairweather, Catherina L. Chang, Christine Tuffery, Robert J. Hancox. Cardiac biomarkers and long-term outcomes of exacerbations of COPD: a long-term follow-up of two cohorts. ERJ Open Res, 7 (1) 00531-2020; 10.1183/23120541.00531-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
CARDIAC DYSFUNCTION IN ACTIVE PULMONARY TUBERCULOSIS: DOUBLE TROUBLE!!
Patterns of cardiopulmonary response to exercise in cardiac diseases
Evaluating the prognosis of cardiac and pulmonary patients
Related content which might interest you:
Do cardiac biomarkers predict long-term outcomes from exacerbations of COPD?
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017
Cardiac biomarkers and outcomes of COPD exacerbations
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019
Long-term benefits of pulmonary rehabilitation in COPD patients: 2 year follow-up
Source: International Congress 2017 – Novel treatments for rehabilitation of patients with chronic respiratory diseases
Year: 2017
Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015
Long-term outcome of pulmonary rehabilitation in COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 244s
Year: 2003
Long-term outcome following first clinically important deterioration in COPD
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016
Gender does not impact the short- or long-term outcomes of home-based pulmonary rehabilitation in patients with COPD
Source: ERJ Open Res, 6 (4) 00032-2020; 10.1183/23120541.00032-2020
Year: 2020
Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Year: 2013
Impact of frailty during hospitalized exacerbations of COPD on 90-day readmissions - preliminary data.
Source: International Congress 2018 – Physiotherapy care for patients with acute and chronic respiratory conditions
Year: 2018
The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Short-term HRQL deterioration during early-phase COPD exacerbation: a prospective Canadian cohort study
Source: Eur Respir J 2005; 26: Suppl. 49, 296s
Year: 2005
The impact of exacerbations on adherence and outcomes of pulmonary rehabilitation in patients with COPD
Source: International Congress 2016 – Management of dyspnoea and exacerbations in chronic lung diseases
Year: 2016
Long-term benefits of pulmonary rehabilitation in patients with chronic asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 454s
Year: 2002
Inhaled corticosteroid withdrawal may improve outcomes in elderly patients with COPD exacerbation: a nationwide database study
Source: ERJ Open Res, 6 (1) 00246-2019; 10.1183/23120541.00246-2019
Year: 2020
Comparisons among various QOL assessments and clinical outcomes for one year in elderly patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 66s
Year: 2004
Associations between clinical, laboratory and therapeutical parameters on admission and adverse outcomes in patients hospitalized for COPD exacerbations
Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management
Year: 2010
Short physical performance battery as a predictor of adverse outcomes following hospitalisation for an acute exacerbation of COPD
Source: International Congress 2016 – Management of dyspnoea and exacerbations in chronic lung diseases
Year: 2016
Long-term effect of low-intensity home-based pulmonary rehabilitation in patients with COPD and non-COPD – a five-year follow-up
Source: Annual Congress 2007 - Assessment and outcomes in non-COPD patients
Year: 2007
Acute exacerbation of COPD (AECOPD) during pulmonary rehabilitation (PR): impact on outcomes and short-term prediction of risk.
Source: International Congress 2017 – Latest insights into chronic care
Year: 2017
Statins and outcome of COPD patients after hospitalization for COPD exacerbations
Source: Annual Congress 2010 - New treatments for asthma and COPD
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept